RAC3 and lung adenocarcinoma: In this study, Rac3 silencing inhibits lung adenocarcinoma cell migration and invasion in vitro and decreases the activity of the p38 MAPK pathway that is required for Rac3-induced migration and invasion, and for Rac3 regulated epithelial to mesenchymal transition.